{
    "Trade/Device Name(s)": [
        "Thermo Scientific QMS\u00ae Everolimus Assay",
        "QMS\u00ae Everolimus Assay"
    ],
    "Submitter Information": "Thermo Fisher Scientific, Clinical Diagnostics Division",
    "510(k) Number": "K122706",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100144"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUF"
    ],
    "Summary Letter Date": "August 20, 2013",
    "Summary Letter Received Date": "July 29, 2013",
    "Submission Date": "July 25, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3840"
    ],
    "Regulation Name(s)": [
        "Sirolimus test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "transplant"
    ],
    "Analyte(s)": [
        "Everolimus"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Particle agglutination assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Homogeneous assay",
        "Optical measurement at 700 nm"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Scientific QMS\u00ae Everolimus Assay, a homogeneous particle agglutination assay for quantifying everolimus in whole blood using automated chemistry analyzers.",
    "Indications for Use Summary": "Quantitative determination of everolimus in human whole blood as an aid in the management of kidney and liver transplant patients receiving everolimus therapy, for clinical laboratory use only.",
    "fda_folder": "Toxicology"
}